These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24250345)

  • 1. Profiling of ecstasy tablets seized in iran.
    Khajeamiri AR; Kobarfard F; Ahmadkhaniha R; Mostashari G
    Iran J Pharm Res; 2011; 10(2):211-20. PubMed ID: 24250345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
    Cheng WC; Poon NL; Chan MF
    J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impurity profiling of ecstasy tablets seized in Hong Kong by gas chromatography-mass spectrometry.
    Cheng JY; Chan MF; Chan TW; Hung MY
    Forensic Sci Int; 2006 Oct; 162(1-3):87-94. PubMed ID: 16860955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005.
    Teng SF; Wu SC; Liu C; Li JH; Chien CS
    Forensic Sci Int; 2006 Sep; 161(2-3):202-8. PubMed ID: 16842946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putting an Ecstasy test kit to the test: harm reduction or harm induction?
    Murray RA; Doering PL; Boothby LA; Merves ML; McCusker RR; Chronister CW; Goldberger BA
    Pharmacotherapy; 2003 Oct; 23(10):1238-44. PubMed ID: 14594341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK.
    Wood DM; Stribley V; Dargan PI; Davies S; Holt DW; Ramsey J
    Emerg Med J; 2011 Sep; 28(9):764-5. PubMed ID: 20724467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of New Psychoactive Substances (NPS) in northeast Brazil: NMR-based identification and analysis of ecstasy tablets by GC-MS.
    Cunha RL; Oliveira CDSL; de Oliveira AL; Maldaner AO; do Desterro Cunha S; Pereira PAP
    Forensic Sci Int; 2023 Mar; 344():111597. PubMed ID: 36801502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of 3,4-methylenedioxymethamphetamine by thin-layer chromatography in ecstasy illicit pills in Tehran.
    Shetab Boushehri SV; Tamimi M; Kebriaeezadeh A
    Toxicol Mech Methods; 2009 Nov; 19(9):565-9. PubMed ID: 20047512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Pharmaceutical Impurities in Ecstasy Tablets: Gas Chromatography-Mass Spectrometry Study.
    Jalali A; Hatamie A; Saferpour T; Khajeamiri A; Safa T; Buazar F
    Iran J Pharm Res; 2016; 15(1):221-9. PubMed ID: 27610162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The variability of ecstasy tablets composition in Brazil.
    Togni LR; Lanaro R; Resende RR; Costa JL
    J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.
    Parrott AC
    Psychopharmacology (Berl); 2004 May; 173(3-4):234-41. PubMed ID: 15007594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
    Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
    Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The content of ecstasy tablets: implications for the study of their long-term effects.
    Cole JC; Bailey M; Sumnall HR; Wagstaff GF; King LA
    Addiction; 2002 Dec; 97(12):1531-6. PubMed ID: 12472637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composition profiling of seized ecstasy tablets by Raman spectroscopy.
    Bell SE; Burns DT; Dennis AC; Matchett LJ; Speers JS
    Analyst; 2000 Oct; 125(10):1811-5. PubMed ID: 11070550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in The Netherlands.
    van Deursen MM; Lock ER; Poortman-van der Meere AJ
    Sci Justice; 2006; 46(3):135-52. PubMed ID: 17388242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Content of ecstasy in the Netherlands: 1993-2008.
    Vogels N; Brunt TM; Rigter S; van Dijk P; Vervaeke H; Niesink RJ
    Addiction; 2009 Dec; 104(12):2057-66. PubMed ID: 19804461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ecstasy tablets intoxication with lethal autcome].
    Dordević S; Tomasević G
    Vojnosanit Pregl; 2007 Sep; 64(9):635-8. PubMed ID: 17969820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of impurities in illicit methamphetamine samples seized in Iran.
    Khajeamiri AR; Faizi M; Sohani F; Baheri T; Kobarfard F
    Forensic Sci Int; 2012 Apr; 217(1-3):204-6. PubMed ID: 22153622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in content and dissolution profiles of MDMA tablets collected in the UK between 2001 and 2018 - A potential risk to users?
    Couchman L; Frinculescu A; Sobreira C; Shine T; Ramsey J; Hecht M; Kipper K; Holt D; Johnston A
    Drug Test Anal; 2019 Aug; 11(8):1172-1182. PubMed ID: 31009168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystals and tablets in the Spanish ecstasy market 2000-2014: Are they the same or different in terms of purity and adulteration?
    Vidal Giné C; Ventura Vilamala M; Fornís Espinosa I; Gil Lladanosa C; Calzada Álvarez N; Fitó Fruitós A; Rodríguez Rodríguez J; Domíngo Salvany A; de la Torre Fornell R
    Forensic Sci Int; 2016 Jun; 263():164-168. PubMed ID: 27129144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.